BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37268061)

  • 21. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
    Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
    Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minichromosome maintenance 3 promotes hepatocellular carcinoma radioresistance by activating the NF-κB pathway.
    Yang Q; Xie B; Tang H; Meng W; Jia C; Zhang X; Zhang Y; Zhang J; Li H; Fu B
    J Exp Clin Cancer Res; 2019 Jun; 38(1):263. PubMed ID: 31208444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
    Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
    Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway.
    Mei J; Lin W; Li S; Tang Y; Ye Z; Lu L; Wen Y; Kan A; Zou J; Yu C; Wei W; Guo R
    J Exp Clin Cancer Res; 2022 Jan; 41(1):5. PubMed ID: 34980201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma.
    Geng X; Geng Z; Li H; Zhang Y; Li J; Chang H
    Liver Int; 2020 Jul; 40(7):1756-1769. PubMed ID: 32174027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-κB.
    Zeng T; Tang Z; Liang L; Suo D; Li L; Li J; Yuan Y; Guan XY; Li Y
    Mol Oncol; 2020 Dec; 14(12):3184-3197. PubMed ID: 33064899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression.
    Li J; Lau G; Chen L; Yuan YF; Huang J; Luk JM; Xie D; Guan XY
    PLoS One; 2012; 7(9):e46264. PubMed ID: 23050001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway.
    Li M; Tan T; Geng Y; Tao Y; Pan J; Zhang J; Xu Q; Shen H; Zuo L; Chen Y
    Ann Hepatol; 2023; 28(1):100759. PubMed ID: 36179794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
    Wang F; Yang JL; Yu KK; Xu M; Xu YZ; Chen L; Lu YM; Fang HS; Wang XY; Hu ZQ; Li FF; Kan L; Luo J; Wang SY
    Mol Cancer; 2015 Jan; 14(1):10. PubMed ID: 25622857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
    Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Lu P; Ding Q; Li X; Ji X; Li L; Fan Y; Xia Y; Tian D; Liu M
    EBioMedicine; 2019 Oct; 48():100-116. PubMed ID: 31597595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
    Dai T; Zhang D; Cai M; Wang C; Wu Z; Ying Z; Wu J; Li M; Xie D; Li J; Song L
    J Pathol; 2015 Feb; 235(3):490-501. PubMed ID: 25385148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
    Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
    BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
    Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
    Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway.
    Lin JP; Huang MH; Sun ZT; Chen L; Lei YH; Huang YQ; Qi M; Fan SR; Chen SG; Chung CW; Chan MC; Liu JS; Hu M; Chen MF; Ye WC; Chen YY; Deng LJ
    Life Sci; 2023 Jul; 324():121715. PubMed ID: 37100377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.